Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
ESMO Open|July 3, 2021
The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey IIK H J Lim, K Murali, K Kamposioras, et al.ESMO Open|February 18, 2021
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaborationS Banerjee, K H J Lim, K Murali, et al.ESMO Open|January 10, 2022
The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey seriesK H J Lim, K Murali, E Thorne, et al.ESMO Open|March 19, 2024
Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study groupL Weiss, L E Fischer, V Heinemann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2022
Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendationsZ Kuzbari, C Bandlamudi, C Loveday, et al.European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'M Haas, J T Siveke, M Schenk, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2018
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)J W Holch, I Ricard, S Stintzing, et al.ESMO Open|November 3, 2023
Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO studyC B Westphalen, J Federer-Gsponer, C Pauli, et al.European Journal of Cancer (Oxford, England : 1990)|August 27, 2017
Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306)D P Modest, I Ricard, S Stintzing, et al.Journal of Cancer Research and Clinical Oncology|April 16, 2023
Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspectiveL Weiss, K Heinrich, D Zhang, et al.Pageof 4